论文部分内容阅读
前列腺素E_1(PGE_1)具有强烈扩张血管、抑制血小板聚集及增强心肌收缩力的作用,目前临床已用于治疗各种心脏病.本文将PGE_1与复方丹参注射液静滴进行疗效对比分析,旨在观察PGE_1对冠心病的治疗价值.1 资料与方法1.1 病例选择:30例患者均为住院病人,男22例,女8例;年龄52～76岁,平均62.47±6.63岁.诊断标准根据1979年WHO对冠心病的分型,陈旧性心梗2例,心绞痛18例,心衰10例(心功能Ⅲ级).1.2 统计方法:给PGE_1前为自身对照组,用PGE_1后与对照组比较,组间比较用两个样本率U检验.1.3 给药方法:30例在给PGE_1前均予复方
Prostaglandin E_1 (PGE_1) has a strong dilation of blood vessels, inhibition of platelet aggregation and enhance myocardial contractility, the current clinical has been used for the treatment of various heart disease.This article will PGE_1 and compound Danshen injection intravenous contrast efficacy analysis, aimed at To observe the value of PGE_1 in the treatment of coronary heart disease.1 Materials and Methods1.1 Case Selection: All 30 patients were hospitalized, including 22 males and 8 females, aged from 52 to 76 years, with an average of 62.47 ± 6.63 years old.According to the diagnostic criteria of 1979 WHO classification of coronary heart disease, 2 cases of old myocardial infarction, 18 cases of angina pectoris, heart failure 10 cases (cardiac function grade) .1.2 Statistical Methods: To PGE_1 as a control group before PGE_1 compared with the control group, Two groups of samples were compared with the U test .1.3 administration method: 30 cases were given before PGE_1 compound